Portfolio company
Surf Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops non-invasive ultrasound devices to treat patients with chronic inflammatory disorders by stimulating the cholinergic anti-inflammatory pathway.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Neuroharmonics
This company develops non-invasive ultrasound devices to modulate deep brain circuits for patients with movement disorders, depression, chronic pain, and addiction.
Ultra Bionics
The company develops implantable ultrasound technologies to provide neuromodulation and neurological disease therapies for patients with conditions such as Parkinson's and epilepsy.
Brain-to-Computer Interface
This company develops ultrasound-based brain-computer interfaces to treat neurological and psychiatric conditions for patients with unmet medical needs.
SonoThera™
This company develops an ultrasound-guided non-viral platform to deliver genetic medicines for patients with chronic and rare diseases.
NeuroBionics
This company develops flexible bioelectronic fibers for endovascular neuromodulation to treat neurological and peripheral nerve disorders in patients without requiring invasive open-brain surgery.
Neuromodulation
This company develops miniaturised peripheral nerve stimulation implants and wireless power systems to treat patients suffering from chronic neuropathic pain.
Boomerang Medical
This company develops bioelectric neuromodulation technology to treat autoimmune diseases, including inflammatory bowel disease, for patients with ulcerative colitis and Crohn's disease.
Attune Neurosciences
This company develops wearable ultrasound neurostimulation devices for patients and government agencies to treat brain disorders and improve cognitive performance.
